DBL pharma launches Seretrol-F Sykonahaler

DBL pharma recently unveiled Seretrol-F Sykonahaler, which is a technologically advanced Multi-Dose Dry Powder Inhaler. This device will ensure precise treatment for the management of Asthma & COPD and overcome the limitation of the conventional devices. The grand launching event is endorsed by Bangladesh Lung Foundation (BLF) and held at Sheraton Banani, Dhaka on 05 Dec 2024 where more than 120 renowned physicians were present.
The launch event was graced by the chief guest Prof. Dr. Md Ali Hossain, President, Bangladesh Lung Foundation & Ex Director, NIDCH, the special guests Dr. Asif Mujtaba Mahmud, Secretary General, BLF & Senior Consultant, Respiratory Medicine, United Hospital; Dr. Kazi Saifuddin Bennoor, Joint Secretary, BLF & Senior Consultant, Respiratory Medicine, United Hospital. From DBL Group, M. A. Jabbar, Managing Director, and from DBL Pharmaceuticals, Ahmed Kamrul Alam, Executive Director, Business Operations, and Khurshid Alam, Site Head were present along with other senior officials from both DBL Group and DBL Pharmaceuticals.